Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-07-06 Purchase | 2021-07-08 5:21 pm | Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner | 450,000 | $14.88 | $6,696,000 | 3,417,075 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-10-25 5:52 pm | N/A N/A | Inhibikase Therapeutics Inc. | IKT | Sands Capital Life Sciences Pulse Fund II L.P. Sands Capital Ventures LLC SANDS FRANK M. 10% Owner | 0 | $0 | 10,950,000 (Direct) | View |
| 2021-07-06 Conversion | 2021-07-08 5:21 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner | 2,967,075 | $0 | 3,417,075 (Direct) | View |
Ownership | 2021-06-30 8:10 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner | 0 | $0 | 2,967,075 (Direct) | View |